Not logged in |
Login
skip to content
Rare Cancer News & Clinical Trials » Google - Bile Duct Cancer
Share
|
H
ome
RCA
Support Forums
Dictionary
Search News
Feeds
Categories
Tags
Feeds
32878
items (
32878
unread) in
74
feeds
Acinar Cell Carcinoma
(522 unread)
Google - Acinar Cell Carcinoma
(358 unread)
PubMed - Acinar Cell Carcinoma
(150 unread)
Trial - Acinar Cell Carcinoma
(14 unread)
Acinic Cell Carcinoma
(306 unread)
Google - Acinic Cell Carcinoma
(155 unread)
PubMed - Acinic Cell Carcinoma
(150 unread)
Trial - Acinic Cell Carcinoma
(1 unread)
Adenoid Cystic Carcinoma
(550 unread)
Google - Adenoid Cystic Carcinoma
(506 unread)
PubMed - Adenoid Cystic Carcinoma
(6 unread)
Trial - Adenoid Cystic Carcinoma
(38 unread)
Adrenal Gland Cancer
(2410 unread)
Google - Adrenal Cancer
(597 unread)
Google - Adrenocortical Carcinoma
(595 unread)
PubMed - Adrenal Cancer
(701 unread)
PubMed - Adrenocortical Carcinoma
(233 unread)
Trial - Adrenal Cancer
(218 unread)
Trial - Adrenocortical Carcinoma
(66 unread)
Ampulla Of Vater
(469 unread)
Google - Ampullary Cancer
(316 unread)
PubMed - Ampullary Cancer
(140 unread)
Trial - Ampullary Carcinoma
(13 unread)
Anal Cancer
(2709 unread)
Google - Anal Cancer
(1026 unread)
PubMed - Anal Cancer
(1428 unread)
Trial - Anal Cancers
(255 unread)
Angiosarcoma
(990 unread)
Google - Angiosarcoma
(591 unread)
PubMed - Angiosarcoma
(374 unread)
Trial - Angiosarcoma
(25 unread)
Appendix Cancer
(684 unread)
Google - Appendix Cancer
(312 unread)
PubMed - Appendix Cancer
(259 unread)
Trial - Appendix Cancer
(113 unread)
Bile Duct Cancer
(4355 unread)
Google - Bile Duct Cancer
(798 unread)
Google - Cholangiocarcinoma
(795 unread)
PubMed - Bile Duct Cancer
(707 unread)
PubMed - Cholangiocarcinoma
(1351 unread)
Trial - Bile Duct Cancer
(388 unread)
Trial - Cholangiocarcinoma
(316 unread)
Brain and CNS
(6120 unread)
Google - Rare Brain Tumor
(520 unread)
Google - Rare CNS Tumor
(493 unread)
PubMed - Ganglioglioma
(72 unread)
PubMed - Rare Brain Tumor
(721 unread)
PubMed - Rare CNS Tumor
(483 unread)
Trial - Brain Tumor
(1975 unread)
Trial - CNS Tumor
(1849 unread)
Trial - Ganglioglioma
(7 unread)
Carcinoid
(887 unread)
Google - Carcinoid
(570 unread)
PubMed - Carcinoid
(311 unread)
Trials - Carcinoid
(6 unread)
Endocrine/Neuroendocrine
(5825 unread)
Google - Merkel Cell Cancer
(418 unread)
Google - Neuroendocrine Tumor
(883 unread)
PubMed - Merkel Cell Cancer
(235 unread)
PubMed - Neuroendocrine Tumor
(3053 unread)
Trial - Merkel Cell Cancer
(71 unread)
Trial - Neuroendocrine Cancers
(1165 unread)
Gall Bladder Cancer
(1132 unread)
Google - Gall Bladder Cancer
(696 unread)
PubMed - Gall Bladder Cancer
(312 unread)
Trials - Gall Bladder Cancer
(124 unread)
Hemangioendothelioma
(1176 unread)
Google - Hemangioendothelioma
(263 unread)
PubMed - Hemangioendothelioma
(897 unread)
Trial - Hemangioendothelioma
(16 unread)
Hepatoblastoma
(770 unread)
Google - Hepatoblastoma
(542 unread)
PubMed - Hepatoblastoma
(192 unread)
Trial - Hepatoblastoma
(36 unread)
Pancreas
(563 unread)
Google - Insulinoma
(348 unread)
PubMed - Insulinoma
(207 unread)
Trial - Insulinoma
(8 unread)
Phyllodes
(384 unread)
Google - Phyllodes Tumor
(260 unread)
PubMed - Phyllodes Tumor
(122 unread)
Trial - Phyllodes
(2 unread)
PMP and Mucinous Tumors
(477 unread)
Google - Pseudomyxoma Peritonei
(340 unread)
PubMed - Pseudomyxoma Peritonei (PMP)
(126 unread)
Trial - Pseudomyxoma Peritonei
(11 unread)
Rhabdomyosarcoma
(1118 unread)
"rhabdomyosarcoma" - Google News
(587 unread)
PubMed - Rhabdomyosarcoma
(438 unread)
Trial - Rhabdomyosarcoma
(93 unread)
Sarcoma
(1431 unread)
"sarcoma" - Google News
(566 unread)
PubMed - Sarcoma
(739 unread)
Trial - Sarcoma
(126 unread)
Show items:
Unread only
Read and unread
Google - Bile Duct Cancer
(100 unread)
1
2
3
...
8
Intrahepatic Cholangiocarcinoma Market Report 2034 | - openPR
Posted:
October
15th
, 2024, 10:58am UTC
Intrahepatic Cholangiocarcinoma Market Report 2034 |
openPR
Biliary Tract Cancer Treatment Market Size, Treatment Drugs, and Companies 2034 | DelveInsight - openPR
Posted:
October
15th
, 2024, 8:16am UTC
Biliary Tract Cancer Treatment Market Size, Treatment Drugs, and Companies 2034 | DelveInsight
openPR
Football rivalry supports father battling cancer - WLWT Cincinnati
Posted:
October
12th
, 2024, 10:39pm UTC
Football rivalry supports father battling cancer
WLWT Cincinnati
Is jaundice a warning sign of cancer? - Roswell Park Comprehensive Cancer Center
Posted:
October
11th
, 2024, 8:00am UTC
Is jaundice a warning sign of cancer?
Roswell Park Comprehensive Cancer Center
Powerhouse classical music producer Adam Abeshouse dies at 63 - NPR
Posted:
October
10th
, 2024, 9:00am UTC
Powerhouse classical music producer Adam Abeshouse dies at 63
NPR
Biliary Tract Cancers (BTCs) Market Industry Overview, Size, and Growth Insights Report 2024 - 2031 - openPR
Posted:
October
10th
, 2024, 4:54am UTC
Biliary Tract Cancers (BTCs) Market Industry Overview, Size, and Growth Insights Report 2024 - 2031
openPR
Cholangiocarcinoma Clinical Trials 2024: EMA, PDMA, FDA - openPR
Posted:
October
8th
, 2024, 7:04am UTC
Cholangiocarcinoma Clinical Trials 2024: EMA, PDMA, FDA
openPR
Costly drugs push man with cancer to apply for medically assisted death - CHCH News
Posted:
October
7th
, 2024, 7:59pm UTC
Costly drugs push man with cancer to apply for medically assisted death
CHCH News
Cancer fighter can feel the love - DoorCountyDailyNews.com
Posted:
October
5th
, 2024, 5:05pm UTC
Cancer fighter can feel the love
DoorCountyDailyNews.com
Stronger together: Miniature robots in convoy transport an endoscopic instrument for microsurgery - Medical Xpress
Posted:
October
1st
, 2024, 10:28am UTC
Stronger together: Miniature robots in convoy transport an endoscopic instrument for microsurgery
Medical Xpress
Bile Duct Cancer Market Share Projections : Competitive - openPR
Posted:
September
26th
, 2024, 6:30am UTC
Bile Duct Cancer Market Share Projections : Competitive
openPR
FGFR2 Fusions More Common in Early-Onset BTC Versus Average-Onset - DocWire News
Posted:
September
25th
, 2024, 12:51pm UTC
FGFR2 Fusions More Common in Early-Onset BTC Versus Average-Onset
DocWire News
Biliary Tract Cancer Pipeline Analysis 2024: FDA Approvals - openPR
Posted:
September
25th
, 2024, 9:54am UTC
Biliary Tract Cancer Pipeline Analysis 2024: FDA Approvals
openPR
Bone mineral density as a prognostic marker in patients with biliary tract cancer undergoing surgery - Nature.com
Posted:
September
23rd
, 2024, 11:31am UTC
Bone mineral density as a prognostic marker in patients with biliary tract cancer undergoing surgery
Nature.com
North America Bile Duct Cancer Drug Market By Application – news - Vaccine Storage & Packaging ...
Posted:
September
14th
, 2024, 11:09am UTC
North America Bile Duct Cancer Drug Market By Application – news
Vaccine Storage & Packaging ...
North America Biliary Tumor Market By Application – news - Vaccine Storage & Packaging ...
Posted:
September
14th
, 2024, 11:09am UTC
North America Biliary Tumor Market By Application – news
Vaccine Storage & Packaging ...
Bile Duct Cancer Market Size, Share, Trends & Forecast - Third Eye News
Posted:
September
13th
, 2024, 6:03am UTC
Bile Duct Cancer Market Size, Share, Trends & Forecast
Third Eye News
New mouse models can boost Japan's drug development: National Cancer Center - The Japan Times
Posted:
September
13th
, 2024, 1:26am UTC
New mouse models can boost Japan's drug development: National Cancer Center
The Japan Times
Bile Duct Cancer Market Insights, Epidemiology, and Market Forecast 2032 Report by Delveinsight - openPR
Posted:
September
11th
, 2024, 10:16pm UTC
Bile Duct Cancer Market Insights, Epidemiology, and Market Forecast 2032 Report by Delveinsight
openPR
Researchers compare tumor characteristics, survival outcome of different bile duct cancers - Medical Xpress
Posted:
September
10th
, 2024, 1:44pm UTC
Researchers compare tumor characteristics, survival outcome of different bile duct cancers
Medical Xpress
Chemotherapy combined with regorafenib and immune checkpoint inhibitors as a first-line treatment for patients with advanced biliary tract cancer: a single arm phase II trial - Frontiers
Posted:
September
9th
, 2024, 12:13pm UTC
Chemotherapy combined with regorafenib and immune checkpoint inhibitors as a first-line treatment for patients with advanced biliary tract cancer: a single arm phase II trial
Frontiers
Claudins: from gatekeepers of epithelial integrity to potential targets in hepato-pancreato-biliary cancers - Frontiers
Posted:
September
5th
, 2024, 11:48am UTC
Claudins: from gatekeepers of epithelial integrity to potential targets in hepato-pancreato-biliary cancers
Frontiers
Clinicopathological features and surgical treatments of intraductal papillary neoplasm of the bile duct: a case report and literature review - Frontiers
Posted:
September
5th
, 2024, 5:21am UTC
Clinicopathological features and surgical treatments of intraductal papillary neoplasm of the bile duct: a case report and literature review
Frontiers
Tumor-associated macrophages: orchestrators of cholangiocarcinoma progression - Frontiers
Posted:
September
3rd
, 2024, 11:55pm UTC
Tumor-associated macrophages: orchestrators of cholangiocarcinoma progression
Frontiers
Immune Phenotyping Identified as Promising Predictive Biomarker by Lunit AI in Biliary Tract Cancer - New publication in CCR - BusinessKorea
Posted:
September
2nd
, 2024, 8:19pm UTC
Immune Phenotyping Identified as Promising Predictive Biomarker by Lunit AI in Biliary Tract Cancer - New publication in CCR
BusinessKorea
Chemotherapy combined with lenvatinib and PD-1 may be a potential better alternative option for advanced unresectable intrahepatic cholangiocarcinoma: a retrospective real-world study - Frontiers
Posted:
September
2nd
, 2024, 2:00am UTC
Chemotherapy combined with lenvatinib and PD-1 may be a potential better alternative option for advanced unresectable intrahepatic cholangiocarcinoma: a retrospective real-world study
Frontiers
UCK2 promotes intrahepatic cholangiocarcinoma progression and desensitizes cisplatin treatment by PI3K/AKT/mTOR/autophagic axis - Nature.com
Posted:
August
23rd
, 2024, 1:43pm UTC
UCK2 promotes intrahepatic cholangiocarcinoma progression and desensitizes cisplatin treatment by PI3K/AKT/mTOR/autophagic axis
Nature.com
Unveiling novel serum biomarkers in intrahepatic cholangiocarcinoma: a pilot proteomic exploration - Frontiers
Posted:
August
21st
, 2024, 9:27pm UTC
Unveiling novel serum biomarkers in intrahepatic cholangiocarcinoma: a pilot proteomic exploration
Frontiers
Bile Duct Cancer Treatment Market Growing Rapidly by 2031 - - openPR
Posted:
August
21st
, 2024, 3:26am UTC
Bile Duct Cancer Treatment Market Growing Rapidly by 2031 -
openPR
Bevacizumab-Erlotinib as Switch Maintenance Therapy for BTC - DocWire News
Posted:
August
20th
, 2024, 4:33pm UTC
Bevacizumab-Erlotinib as Switch Maintenance Therapy for BTC
DocWire News
Bevacizumab-Erlotinib as Switch Maintenance Therapy for BTC - DocWire News
Posted:
August
20th
, 2024, 2:00am UTC
Bevacizumab-Erlotinib as Switch Maintenance Therapy for BTC
DocWire News
Prognostic factors in patients with intrahepatic cholangiocarcinoma - Nature.com
Posted:
August
17th
, 2024, 7:43am UTC
Prognostic factors in patients with intrahepatic cholangiocarcinoma
Nature.com
Anatomical classification of advanced biliary tract cancer predicts programmed cell death protein 1 blockade efficacy - Frontiers
Posted:
August
16th
, 2024, 2:11pm UTC
Anatomical classification of advanced biliary tract cancer predicts programmed cell death protein 1 blockade efficacy
Frontiers
AMDHD1 acts as a tumor suppressor and contributes to activation of TGF-β signaling pathway in cholangiocarcinoma - Nature.com
Posted:
August
14th
, 2024, 2:59pm UTC
AMDHD1 acts as a tumor suppressor and contributes to activation of TGF-β signaling pathway in cholangiocarcinoma
Nature.com
Cost-effectiveness of pembrolizumab plus chemotherapy vs. chemotherapy as first-line treatment for advanced biliary tract cancer in China and the US - Frontiers
Posted:
August
14th
, 2024, 12:26am UTC
Cost-effectiveness of pembrolizumab plus chemotherapy vs. chemotherapy as first-line treatment for advanced biliary tract cancer in China and the US
Frontiers
Research Recap: Younger Adults at a Higher Risk of 17 Cancers - Verywell Health
Posted:
August
7th
, 2024, 2:54pm UTC
Research Recap: Younger Adults at a Higher Risk of 17 Cancers
Verywell Health
MSH6 germline mutations leading to Lynch syndrome-associated cholangiocarcinoma: a case report - Frontiers
Posted:
August
5th
, 2024, 12:35am UTC
MSH6 germline mutations leading to Lynch syndrome-associated cholangiocarcinoma: a case report
Frontiers
Bile duct cancer: existing leukaemia treatment could hold promise – mouse study - Yahoo News Canada
Posted:
August
2nd
, 2024, 9:24am UTC
Bile duct cancer: existing leukaemia treatment could hold promise – mouse study
Yahoo News Canada
PUM1-TRAF3 fusion protein activates non-canonical NF-κB signaling via rescued NIK in biliary tract cancer - Nature.com
Posted:
August
1st
, 2024, 3:33pm UTC
PUM1-TRAF3 fusion protein activates non-canonical NF-κB signaling via rescued NIK in biliary tract cancer
Nature.com
Incidence risk of hepatobiliary malignant neoplasms in the cohort of workers chronically exposed to ionizing radiation - Nature.com
Posted:
July
30th
, 2024, 2:38pm UTC
Incidence risk of hepatobiliary malignant neoplasms in the cohort of workers chronically exposed to ionizing radiation
Nature.com
Finding a rare bile duct cancer’s weaknesses - Fred Hutchinson Cancer Center
Posted:
July
30th
, 2024, 10:03am UTC
Finding a rare bile duct cancer’s weaknesses
Fred Hutchinson Cancer Center
Bile Duct Cancer: Surgery Is Best Chance of Survival - Yahoo Singapore News
Posted:
July
30th
, 2024, 6:26am UTC
Bile Duct Cancer: Surgery Is Best Chance of Survival
Yahoo Singapore News
Alberta's coverage of new treatment for rare cancer providing hope for patients - CTV News Calgary
Posted:
July
25th
, 2024, 6:59am UTC
Alberta's coverage of new treatment for rare cancer providing hope for patients
CTV News Calgary
Hot Peeps Beat is back - taylorpress.net
Posted:
July
23rd
, 2024, 8:09pm UTC
Hot Peeps Beat is back
taylorpress.net
Alberta's coverage of new treatment for rare cancer providing hope for patients - CTV News Calgary
Posted:
July
23rd
, 2024, 10:13pm UTC
Alberta's coverage of new treatment for rare cancer providing hope for patients
CTV News Calgary
Koi Pla, Probably the World’s Deadliest Dish - Oddity Central
Posted:
July
22nd
, 2024, 3:40pm UTC
Koi Pla, Probably the World’s Deadliest Dish
Oddity Central
Koi Pla, Probably the World’s Deadliest Dish - Oddity Central
Posted:
July
22nd
, 2024, 3:40pm UTC
Koi Pla, Probably the World’s Deadliest Dish
Oddity Central
FIGHT-202: Analyzing the Effects of Pemigatinib in Patients With Cholangiocarcinoma - DocWire News
Posted:
July
22nd
, 2024, 6:48am UTC
FIGHT-202: Analyzing the Effects of Pemigatinib in Patients With Cholangiocarcinoma
DocWire News
Alberta's coverage of new treatment for rare cancer providing hope for patients - CTV News Calgary
Posted:
July
22nd
, 2024, 12:37am UTC
Alberta's coverage of new treatment for rare cancer providing hope for patients
CTV News Calgary
Hepatic artery infusion improves treatment for cancer in the liver - Roswell Park Comprehensive Cancer Center
Posted:
July
19th
, 2024, 9:39am UTC
Hepatic artery infusion improves treatment for cancer in the liver
Roswell Park Comprehensive Cancer Center
Durvalumab Plus Chemo Shows Sustained Survival Benefit in Advanced Biliary Tract Cancer - www.oncnursingnews.com/
Posted:
July
19th
, 2024, 9:04am UTC
Durvalumab Plus Chemo Shows Sustained Survival Benefit in Advanced Biliary Tract Cancer
www.oncnursingnews.com/
Bile Duct Cancer Market to See Booming Growth 2024-2031 | - openPR
Posted:
July
19th
, 2024, 5:45am UTC
Bile Duct Cancer Market to See Booming Growth 2024-2031 |
openPR
Bile Duct Cancer Market to See Booming Growth 2024-2031 | - openPR
Posted:
July
19th
, 2024, 2:00am UTC
Bile Duct Cancer Market to See Booming Growth 2024-2031 |
openPR
Pediatric Biliary Atresia: Practice Essentials, Background, Pathophysiology - Medscape Reference
Posted:
July
19th
, 2024, 2:00am UTC
Pediatric Biliary Atresia: Practice Essentials, Background, Pathophysiology
Medscape Reference
Alberta's coverage of new treatment for rare cancer providing hope for patients - CTV News Calgary
Posted:
July
18th
, 2024, 7:03pm UTC
Alberta's coverage of new treatment for rare cancer providing hope for patients
CTV News Calgary
The role of immune checkpoint inhibitors in the first-line treatment for patients with advanced biliary tract cancer: a systematic review and meta-analysis of randomized trials - Frontiers
Posted:
July
17th
, 2024, 2:00am UTC
The role of immune checkpoint inhibitors in the first-line treatment for patients with advanced biliary tract cancer: a systematic review and meta-analysis of randomized trials
Frontiers
Lisata Therapeutics Announces Completion of Enrollment in its Phase 2a BOLSTER Trial of Certepetide in First-Line Cholangiocarcinoma - StockTitan
Posted:
July
16th
, 2024, 7:00am UTC
Lisata Therapeutics Announces Completion of Enrollment in its Phase 2a BOLSTER Trial of Certepetide in First-Line Cholangiocarcinoma
StockTitan
Case report: Translational treatment of unresectable intrahepatic cholangiocarcinoma: Tislelizumab, Lenvatinib, and GEMOX in one case - Frontiers
Posted:
July
14th
, 2024, 2:00am UTC
Case report: Translational treatment of unresectable intrahepatic cholangiocarcinoma: Tislelizumab, Lenvatinib, and GEMOX in one case
Frontiers
Alberta's coverage of new treatment for rare cancer providing hope for patients - CTV News Calgary
Posted:
July
13th
, 2024, 8:21am UTC
Alberta's coverage of new treatment for rare cancer providing hope for patients
CTV News Calgary
Bile Duct Cancer (Cholangiocarcinoma) Drugs, FDA Approvals, - openPR
Posted:
July
12th
, 2024, 10:16pm UTC
Bile Duct Cancer (Cholangiocarcinoma) Drugs, FDA Approvals,
openPR
Lisata announces promising preclinical results in cholangiocarcinoma study - Proactive Investors USA
Posted:
July
11th
, 2024, 5:41pm UTC
Lisata announces promising preclinical results in cholangiocarcinoma study
Proactive Investors USA
Curcumin synergistically enhances the efficacy of gemcitabine against gemcitabine-resistant cholangiocarcinoma via the targeting LAT2/glutamine pathway - Nature.com
Posted:
July
11th
, 2024, 11:11am UTC
Curcumin synergistically enhances the efficacy of gemcitabine against gemcitabine-resistant cholangiocarcinoma via the targeting LAT2/glutamine pathway
Nature.com
Lisata’s Certepetide: promising preclinical results in cholangiocarcinoma - Proactive Investors USA
Posted:
July
11th
, 2024, 10:44am UTC
Lisata’s Certepetide: promising preclinical results in cholangiocarcinoma
Proactive Investors USA
Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size | Global Demand and Business Trends 2032 - WICZ
Posted:
July
11th
, 2024, 2:00am UTC
Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size | Global Demand and Business Trends 2032
WICZ
Curcumin synergistically enhances the efficacy of gemcitabine against gemcitabine-resistant cholangiocarcinoma via the targeting LAT2/glutamine pathway - Nature.com
Posted:
July
11th
, 2024, 2:00am UTC
Curcumin synergistically enhances the efficacy of gemcitabine against gemcitabine-resistant cholangiocarcinoma via the targeting LAT2/glutamine pathway
Nature.com
Lisata Therapeutics’ Certepetide Shows Promise in Improving Standard Treatment for Intrahepatic Cholangiocarcinoma in a Preclinical Model - StockTitan
Posted:
July
10th
, 2024, 7:00am UTC
Lisata Therapeutics’ Certepetide Shows Promise in Improving Standard Treatment for Intrahepatic Cholangiocarcinoma in a Preclinical Model
StockTitan
Imugene doses first patient for VAXINIA bile tract cancer trial in Melbourne - Proactive Investors USA
Posted:
July
9th
, 2024, 7:35pm UTC
Imugene doses first patient for VAXINIA bile tract cancer trial in Melbourne
Proactive Investors USA
Imugene doses first patient for VAXINIA bile tract cancer trial in Melbourne - Proactive Investors Australia
Posted:
July
9th
, 2024, 7:35pm UTC
Imugene doses first patient for VAXINIA bile tract cancer trial in Melbourne
Proactive Investors Australia
Causal relationship between immune cell phenotypes and risk of biliary tract cancer: evidence from Mendelian randomization analysis - Frontiers
Posted:
July
9th
, 2024, 2:00am UTC
Causal relationship between immune cell phenotypes and risk of biliary tract cancer: evidence from Mendelian randomization analysis
Frontiers
Tumor-infiltrating T lymphocytes: A promising immunotherapeutic target for preventing immune escape in cholangiocarcinoma - ScienceDirect.com
Posted:
July
8th
, 2024, 4:08pm UTC
Tumor-infiltrating T lymphocytes: A promising immunotherapeutic target for preventing immune escape in cholangiocarcinoma
ScienceDirect.com
Cholangiocarcinoma of the Middle Bile Duct: A Narrative Review - springermedicine.com
Posted:
July
7th
, 2024, 2:00am UTC
Cholangiocarcinoma of the Middle Bile Duct: A Narrative Review
springermedicine.com
Biliary Stent Market Analysis Current Landscape and Future Outlook - Taiwan News
Posted:
July
4th
, 2024, 8:21pm UTC
Biliary Stent Market Analysis Current Landscape and Future Outlook
Taiwan News
Bile Duct Cancer Market Size, Insights 2031 by Key Vendors- F. - openPR
Posted:
July
4th
, 2024, 12:43pm UTC
Bile Duct Cancer Market Size, Insights 2031 by Key Vendors- F.
openPR
Liao Highlights Treatment Selection Considerations and Key Data in Biliary Tract Cancer - OncLive
Posted:
July
3rd
, 2024, 4:08pm UTC
Liao Highlights Treatment Selection Considerations and Key Data in Biliary Tract Cancer
OncLive
Game of Thrones actor Ian Gelder dies at 74 due to bile duct cancer: All about it - MSN
Posted:
July
3rd
, 2024, 12:32pm UTC
Game of Thrones actor Ian Gelder dies at 74 due to bile duct cancer: All about it
MSN
Durvalumab Plus Chemo Maintains OS Benefit in Advanced Biliary Tract Cancer - OncLive
Posted:
July
1st
, 2024, 2:00am UTC
Durvalumab Plus Chemo Maintains OS Benefit in Advanced Biliary Tract Cancer
OncLive
Ian Gelder: Game Of Thrones actor dies aged 74 after being diagnosed with bile duct cancer - Yahoo New Zealand News
Posted:
June
30th
, 2024, 9:34pm UTC
Ian Gelder: Game Of Thrones actor dies aged 74 after being diagnosed with bile duct cancer
Yahoo New Zealand News
Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Report 2024-2032 | 128 Pages Report - WICZ
Posted:
June
30th
, 2024, 4:14am UTC
Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Report 2024-2032 | 128 Pages Report
WICZ
Evaluation of the outcomes of biliary-enteric reconstruction in robotic radical resection of hilar cholangiocarcinoma: a ... - Nature.com
Posted:
June
27th
, 2024, 6:49am UTC
Evaluation of the outcomes of biliary-enteric reconstruction in robotic radical resection of hilar cholangiocarcinoma: a ...
Nature.com
Dramatic improvements in outcome following pancreatoduodenectomy for pancreatic and periampullary cancers - Nature.com
Posted:
June
27th
, 2024, 2:00am UTC
Dramatic improvements in outcome following pancreatoduodenectomy for pancreatic and periampullary cancers
Nature.com
Evaluation of the outcomes of biliary-enteric reconstruction in robotic radical resection of hilar cholangiocarcinoma: a single-center propensity score matching analysis - Nature.com
Posted:
June
27th
, 2024, 2:00am UTC
Evaluation of the outcomes of biliary-enteric reconstruction in robotic radical resection of hilar cholangiocarcinoma: a single-center propensity score matching analysis
Nature.com
Intrahepatic Cholangiocarcinoma Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Therapies and Key ... - openPR
Posted:
June
25th
, 2024, 3:38pm UTC
Intrahepatic Cholangiocarcinoma Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Therapies and Key ...
openPR
Editorial: Novel therapeutic approaches for biliary tract cancer and hepatocellular carcinoma - Frontiers
Posted:
June
25th
, 2024, 11:11am UTC
Editorial: Novel therapeutic approaches for biliary tract cancer and hepatocellular carcinoma
Frontiers
Global, regional, and national burden and trends analysis of gallbladder and biliary tract cancer from 1990 to 2019 and predictions to 2030: a systematic analysis for the Global Burden of Disease Study 2019 - Frontiers
Posted:
June
25th
, 2024, 7:53am UTC
Global, regional, and national burden and trends analysis of gallbladder and biliary tract cancer from 1990 to 2019 and predictions to 2030: a systematic analysis for the Global Burden of Disease Study 2019
Frontiers
Cholangiocarcinoma Market Expected to Expand at a Steady 2024-2031 - openPR
Posted:
June
24th
, 2024, 6:18am UTC
Cholangiocarcinoma Market Expected to Expand at a Steady 2024-2031
openPR
Alberta covering treatment for patients with bile duct cancer - CTV News Calgary
Posted:
June
21st
, 2024, 3:47pm UTC
Alberta covering treatment for patients with bile duct cancer
CTV News Calgary
Treatment for Stomach Cancer - Nebraska Medicine
Posted:
June
21st
, 2024, 5:08am UTC
Treatment for Stomach Cancer
Nebraska Medicine
Alberta's coverage of new treatment for rare cancer providing hope for patients - CTV News Calgary
Posted:
June
21st
, 2024, 4:34am UTC
Alberta covering treatment for patients with bile duct cancer
CTV News Calgary
Biliary Tract Cancer Market Poised for Remarkable Growth in APAC Over the Next Decade - openPR
Posted:
June
21st
, 2024, 2:24am UTC
Biliary Tract Cancer Market Poised for Remarkable Growth in APAC Over the Next Decade
openPR
Dr Pant on the Utility of Zanidatamab in Previously Treated HER2+ Biliary Tract Cancer - OncLive
Posted:
June
20th
, 2024, 5:27pm UTC
Dr Pant on the Utility of Zanidatamab in Previously Treated HER2+ Biliary Tract Cancer
OncLive
Study highlights importance of early detection in bile duct cancer for patients with rare liver disease - Medical Xpress
Posted:
June
20th
, 2024, 2:38pm UTC
Study highlights importance of early detection in bile duct cancer for patients with rare liver disease
Medical Xpress
Gallbladder and Bile Duct Cancers: 4 Things to Know - Fox Chase Cancer Center
Posted:
June
20th
, 2024, 2:00am UTC
Gallbladder and Bile Duct Cancers: 4 Things to Know
Fox Chase Cancer Center
Study highlights importance of early detection in bile duct cancer for patients with rare liver disease - Medical Xpress
Posted:
June
20th
, 2024, 2:00am UTC
Study highlights importance of early detection in bile duct cancer for patients with rare liver disease
Medical Xpress
Immunotherapies transforming biliary tract cancer care, despite access hurdles - KBR
Posted:
June
20th
, 2024, 11:42pm UTC
Immunotherapies transforming biliary tract cancer care, despite access hurdles
KBR
For overlooked cholangiocarcinoma patients, there’s a light at the end of the tunnel - Fred Hutchinson Cancer Center
Posted:
June
19th
, 2024, 2:00am UTC
For overlooked cholangiocarcinoma patients, there’s a light at the end of the tunnel
Fred Hutchinson Cancer Center
Biliary Tract Cancer Pipeline Drugs Analysis Report (2024 Updates): FDA Approvals, Clinical Trials, Therapies ... - openPR
Posted:
June
18th
, 2024, 3:18pm UTC
Biliary Tract Cancer Pipeline Drugs Analysis Report (2024 Updates): FDA Approvals, Clinical Trials, Therapies ...
openPR
Bile Duct Cancer (Cholangiocarcinoma) Pipeline Report 2024 | Clinical Trials, FDA, EMA, PMDA Approvals, Drugs ... - openPR
Posted:
June
17th
, 2024, 5:48pm UTC
Bile Duct Cancer (Cholangiocarcinoma) Pipeline Report 2024 | Clinical Trials, FDA, EMA, PMDA Approvals, Drugs ...
openPR
Liraglutide exhibits potential anti-tumor effects on the progression of intrahepatic cholangiocarcinoma, in vitro and in ... - Nature.com
Posted:
June
14th
, 2024, 2:11am UTC
Liraglutide exhibits potential anti-tumor effects on the progression of intrahepatic cholangiocarcinoma, in vitro and in ...
Nature.com
Liraglutide exhibits potential anti-tumor effects on the progression of intrahepatic cholangiocarcinoma, in vitro and in vivo - Nature.com
Posted:
June
14th
, 2024, 2:00am UTC
Liraglutide exhibits potential anti-tumor effects on the progression of intrahepatic cholangiocarcinoma, in vitro and in vivo
Nature.com
Alberta covering treatment for patients with bile duct cancer - CTV News Calgary
Posted:
June
13th
, 2024, 11:42am UTC
Alberta covering treatment for patients with bile duct cancer
CTV News Calgary
1
2
3
...
8
← Trial - Appendix Cancer
Google - Cholangiocarcinoma →